Hemo Organic524590Board meeting scheduled
Board meeting on 17 October 2026 to consider un-audited results for the quarter and half year ended 30 September 2026
Hemo Organic Ltd has informed BSE that its Board of Directors will meet on Saturday, 17 October 2026 at 4:00 p.m.
By ScoutQuest · · 2 min read
- Board Meeting Date
- Saturday, 17 October 2026
- Board Meeting Time
- 4:00 p.m.
- Agenda
- un-audited financial results for the quarter and half year ended 30 September 2026
Board meeting scheduled for 17 October 2026
- Hemo Organic Ltd has informed BSE that a meeting of its Board of Directors is scheduled to be held on Saturday, 17 October 2026 at 4:00 p.m.
- The main agenda item is to consider and approve the un-audited financial results of the company for the quarter and half year ended 30 September 2026, along with the Limited Review Report thereon.
- The notice also mentions other business to be transacted as per the agenda being circulated.
What the agenda items mean
- Un-audited financial results: These are the company's periodic numbers that have not been through a full statutory audit.
- Limited Review Report: This is the report issued by the company's auditors after a limited review of the results, and it is shared along with them. A limited review gives a narrower level of assurance than a full audit.
- Quarter and half year ended 30 September 2026: The results cover both the three-month period and the six-month period ending on that date. Many listed companies report both together.
How to read this announcement
- This is an intimation that a Board meeting has been called, not the results themselves. The numbers are to be considered and approved at the meeting.
- Such notices are part of the regular disclosure cycle listed companies follow ahead of Board meetings, so that the market knows when results-related decisions are expected.
- For a retail investor, the useful information here is the date and the agenda: it tells you when the company's September-quarter numbers are scheduled to be taken up by the Board.
Points to keep in mind
- This intimation does not indicate the direction of the results, whether profit or loss.
- The performance details will be in the results that are considered and approved at the meeting, along with the Limited Review Report.
Also from Hemo Organic
Standalone results for the quarter ended 30.09.2026 (Unaudited)
17 Oct 2026
Board approves unaudited Q2 and half-year results; auditor's review carries a qualified opinion
17 Oct 2026
Withdrawal of consent to act as Company Secretary and Compliance Officer; proposed appointment did not take effect
14 Oct 2026
Source: BSE · 14 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.